The COVID-19 pandemic created unprecedented challenges to meet blood supply demands, thus resulting in significant blood shortages. As a means to mitigate shortages, the FDA released revised guidance for HIV, malaria, and vCJD that contained numerous recommendations for changes in donor deferral. These recommendations required the development and release of the Donor History Questionnaire (DHQ) v2.1. Even under normal circumstances, implementation of major donor deferral changes requires significant time and resources. This was exacerbated by the pandemic. In this session, the AABB Donor History Task Force and others will present the following:
An overview of resources to aid in implementation of the Donor History Questionnaire (DHQ)
Data collected through surveys and focus groups detailing challenges and successes in implementing the DHQ v2.1 during the COVID-19 pandemic
First-hand experience from a blood center in overcoming challenges and finding opportunities during the pandemic
To view Spanish or English subtitles, click the "CC" box in the video player. Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Identify what resources and tools are available to aid in the implementation of changes to the Donor History Questionnaire (DHQ).
Describe common challenges, successes and opportunities for improvement in implementing a DHQ during the pandemic.
Utilize lessons learned and first-hand experience from other centers on how overcome these challenges.
All relevant financial relationships have been mitigated. By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM21-21: Challenges and Triumphs from the Implementation of Major Donor Eligibility Changes during a Global Pandemic Evaluation